title: Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells.
abstract: Hepatitis C virus (HCV) subgenomic replicon has been reported to replicate efficiently and continuously in human hepatoma Huh-7 cells. To extend the previous results to other isolated HCV clones, we constructed another HCV replicon from HC-J4, one of chimpanzee-infectious HCV clones. An HCV replicon derived from HC-J4 (RpJ4) consists of HCV-5' untranslated region, neomycin phosphotransferase gene, the encephalomyocarditis virus internal ribosomal entry site, HCV nonstructural region, NS3 to NS5B, and HCV-3' untranslated region. The adaptive mutations known to be required for HCV-Con1 replicon were introduced in RpJ4 replicon, aa.(amino acids number according to HC-J4) 2197 serine to proline, deletion of serine at aa.2201, and aa.2204 serine to isoleucine (RpJ4-S2197P, RpJ4-S22001del, and RpJ4-S2204I). RpJ4/ISDR mutant and RpJ4-S2201del/ISDR mutant were also constructed by introducing six amino acid mutations into the interferon sensitivity determining region (ISDR). After transfection into Huh-7 cells and G418 selection, RpJ4 and RpJ4/ISDR mutants did not produce any colony. In contrast, G418-resistant cells were transduced efficiently by RpJ4-S2197P, RpJ4-S2204I, RpJ4-S2201del and RpJ4-S2201del/ISDR mutant, with the RpJ4-S2201del/ISDR mutant being most efficient. Hence the HCV replicon derived from HC-J4 can replicate efficiently following the introduction of adaptive mutations into the upstream region of ISDR. Moreover, additional introduction of mutations into ISDR further enhanced its replication. These findings demonstrate that the genetic structure of the NS5A domain is critical in HCV replications.
authors.affiliation: Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Maekawa
authors.forename: N
authors.initials: N
authors.lastname: Enomoto
authors.forename: N
authors.initials: N
authors.lastname: Sakamoto
authors.forename: M
authors.initials: M
authors.lastname: Kurosaki
authors.forename: E
authors.initials: E
authors.lastname: Ueda
authors.forename: T
authors.initials: T
authors.lastname: Kohashi
authors.forename: H
authors.initials: H
authors.lastname: Watanabe
authors.forename: C-H
authors.initials: CH
authors.lastname: Chen
authors.forename: T
authors.initials: T
authors.lastname: Yamashiro
authors.forename: Y
authors.initials: Y
authors.lastname: Tanabe
authors.forename: N
authors.initials: N
authors.lastname: Kanazawa
authors.forename: M
authors.initials: M
authors.lastname: Nakagawa
authors.forename: C
authors.initials: C
authors.lastname: Sato
authors.forename: M
authors.initials: M
authors.lastname: Watanabe
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D003001:Cloning, Molecular; D016679:Genome, Viral; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity* / Q000502:physiology; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology; D008969:Molecular Sequence Data; D009154:Mutation; D002679:Pan troglodytes; D012093:Replicon; D014407:Tumor Cells, Cultured; D017361:Viral Nonstructural Proteins / Q000235:genetics*; D014779:Virus Replication; D012324:RNA-Dependent RNA Polymerase
chemical_list: D016898:Interferon-alpha; D017361:Viral Nonstructural Proteins; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase